AGP Executive Report
Last update: 2 minutes agoAbortion Rights in Focus: Liechtenstein’s parliament narrowly backed a bill to legalise abortion up to 12 weeks, but Hereditary Prince Alois has signalled he would veto it, keeping the country’s very restrictive approach in place for now. Diabetes Drug Deal: Menarini struck a major agreement with Gan & Lee to bring its GLP-1 bofanglutide to Europe, with regulatory and commercial work covering EU countries plus Liechtenstein and nearby markets. NHS Workforce Policy: A UK law prioritising home-trained medical graduates for NHS training posts sharply increased the share of “homegrown” doctors taking specialty training places. Public Health Tech & Wearables: Huawei unveiled the WATCH GT 7 series with new outdoor sports modes and health tracking features, aiming at longer battery life for active users. Mobility & Health Access: Germany clarified rules for an 18-month residence permit for non-EU graduates seeking qualified work, including requirements for health insurance and financial support. Cross-Border Rules: Western Balkans truck drivers threatened border blocks over Schengen entry/exit limits, a move that could disrupt travel and logistics affecting healthcare access.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.